Chen, Weineng
Liao, Yu
Shi, Xinchong
Su, Fengjuan
Kong, Haifan
Fang, Yingying
Zheng, Yifan
Zhou, Jiayi
Liu, Ganqiang
Zhou, Xianbo
Yao, Xiaoli
Ashford, Curtis B.
Li, Feng
Yang, Long
Bergeron, Michael F.
Ashford, J. Wesson
Zhang, Xiangsong
Pei, Zhong
Article History
Received: 15 February 2025
Accepted: 29 June 2025
First Online: 5 July 2025
Declarations
:
: This study was performed according to the Helsinki declaration of 1975 and was approved by the ethical committee of the first Affiliated Hospital of Sun Yat-sen University in Guangzhou, Guangdong, China. All participants or guardians voluntarily signed an informed consent.
: Dr. Ashford developed the MemTrax test and consults with his son, Curtis B. Ashford, to market MemTrax commercially. Dr. Zhou worked with Dr. Ashford and Curtis Ashford at MemTrax LLC to develop and implement MemTrax in China, which is marketed commercially by SJN Biomed, where Dr. Zhou was once an executive director. The other authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.